Literature DB >> 18789326

Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.

Sharad S Singhal1, Sushma Yadav, Jyotsana Singhal, Mukesh Sahu, Archana Sehrawat, Sanjay Awasthi.   

Abstract

This study was undertaken to characterize the consequences of Ral-interacting protein (RLIP76)-loss with respect to drug resistance, transport, radiation resistance, and alternative transport mechanisms in mouse embryonic fibroblasts (MEFs). MEFs were derived from RLIP76+/+, RLIP76+/- and RLIP76-/- mice. The transport of doxorubicin (DOX), colchicine (COL), leukotriene C4 and dinitrophenyl S-glutathione (DNP-SG) was analyzed in inside-out vesicles (IOVs) prepared from MEFs. We used immuno-titration of transport activity to determine the contribution of RLIP76, MRP1, and p-glycoprotein (Pgp) towards total transport activity. Loss of RLIP76 alleles resulted in significant sensitization to radiation, DOX, cisplatin, and vinorelbine (VRL). In IOVs prepared from MEFs, we observed a stepwise loss of transport activity. Loss of RLIP76 confers sensitivity to xenobiotics and radiation due to the loss of a common transport mechanism for glutathione-electrophile conjugates and xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789326      PMCID: PMC2586942          DOI: 10.1016/j.febslet.2008.09.001

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.

Authors:  Sharad S Singhal; Sushma Yadav; Jyotsana Singhal; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Biochem Biophys Res Commun       Date:  2006-07-28       Impact factor: 3.575

Review 2.  The glutathione S-transferases: a group of multifunctional detoxification proteins.

Authors:  W B Jakoby
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

3.  Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress.

Authors:  J Z Cheng; R Sharma; Y Yang; S S Singhal; A Sharma; M K Saini; S V Singh; P Zimniak; S Awasthi; Y C Awasthi
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

4.  Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin.

Authors:  S Awasthi; J Cheng; S S Singhal; M K Saini; U Pandya; S Pikula; J Bandorowicz-Pikula; S V Singh; P Zimniak; Y C Awasthi
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

5.  RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.

Authors:  Rajendra Sharma; Sharad S Singhal; Dilki Wickramarachchi; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

Review 6.  Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance.

Authors:  Sanjay Awasthi; Sharad S Singhal; Rajendra Sharma; Piotr Zimniak; Yogesh C Awasthi
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

7.  RLIP76 in defense of radiation poisoning.

Authors:  Jyotsana Singhal; Sharad S Singhal; Sushma Yadav; Sumihiro Suzuki; Molly M Warnke; Adly Yacoub; Paul Dent; Sejong Bae; Rajendra Sharma; Yogesh C Awasthi; Daniel W Armstrong; Sanjay Awasthi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

Review 8.  Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases.

Authors:  Yogesh C Awasthi; Yusong Yang; Narendra K Tiwari; Brad Patrick; Abha Sharma; Jie Li; Sanjay Awasthi
Journal:  Free Radic Biol Med       Date:  2004-09-01       Impact factor: 7.376

9.  Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.

Authors:  Sanjay Awasthi; Sharad S Singhal; Jyotsana Singhal; Jizhong Cheng; Piotr Zimniak; Yogesh C Awasthi
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

Review 10.  Oxidants, antioxidants and the ischemic brain.

Authors:  David S Warner; Huaxin Sheng; Ines Batinić-Haberle
Journal:  J Exp Biol       Date:  2004-08       Impact factor: 3.312

View more
  17 in total

Review 1.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.

Authors:  Sharad S Singhal; Sharda P Singh; Preeti Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-23       Impact factor: 4.219

Review 2.  Role of RLIP76 in doxorubicin resistance in lung cancer.

Authors:  Rit Vatsyayan; Pankaj Chaudhary; Poorna Chandra Rao Lelsani; Preeti Singhal; Yogesh C Awasthi; Sanjay Awasthi; Sharad S Singhal
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

3.  P300 regulates the human RLIP76 promoter activity and gene expression.

Authors:  Archana Sehrawat; Sushma Yadav; Yogesh C Awasthi; Alakananda Basu; Charles Warden; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2013-02-16       Impact factor: 5.858

4.  Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.

Authors:  Ambrose R Kidd; Jared L Snider; Timothy D Martin; Sarah F Graboski; Channing J Der; Adrienne D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

5.  Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.

Authors:  Sharad S Singhal; Dilki Wickramarachchi; Sushma Yadav; Jyotsana Singhal; Kathryn Leake; Rit Vatsyayan; Pankaj Chaudhary; Poorna Lelsani; Sumihiro Suzuki; Shaohua Yang; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Mol Cancer Ther       Date:  2011-01       Impact factor: 6.261

Review 6.  RLIP76 Targeted Therapy for Kidney Cancer.

Authors:  Sharad S Singhal; Jyotsana Singhal; James Figarola; David Horne; Sanjay Awasthi
Journal:  Pharm Res       Date:  2015-05-29       Impact factor: 4.200

Review 7.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

8.  Mouse chromosome 17 candidate modifier genes for thrombosis.

Authors:  Qila Sa; Erika Hart; Joseph H Nadeau; Jane L Hoover-Plow
Journal:  Mamm Genome       Date:  2010-08-11       Impact factor: 2.957

Review 9.  RLIP76: a versatile transporter and an emerging target for cancer therapy.

Authors:  Rit Vatsyayan; Poorna Chandra Rao Lelsani; Sanjay Awasthi; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2010-01-25       Impact factor: 5.858

10.  A central role of RLIP76 in regulation of glycemic control.

Authors:  Sanjay Awasthi; Sharad S Singhal; Sushma Yadav; Jyotsana Singhal; Rit Vatsyayan; Ewa Zajac; Rafal Luchowski; Jozef Borvak; Karol Gryczynski; Yogesh C Awasthi
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.